easily have outstripped the supply of essential medications were it not for exemplary real-time decision-making , compiled a new report outlining how it would ensure Canadians had access to a sustainable resource of generic medicines . The measures suggested include the further development of R & D facilities for drug manufacturing , increasing warehouse capacity and maintaining sufficient domestic quantities of essential pharmaceutical ingredients . The pandemic , therefore , has helped the CGPA and many other pharmaceutical organisations accelerate reform in areas which were already flawed . Perhaps the silver-lining of the disruption has been the rallying effect on the industry to combat supply chain weaknesses which seemed unurgent prior to this global test . “ The resilience of Canada ’ s generic pharmaceutical industry has been tested ,” said Jim Keon , President of CGPA , in a press release . “ The COVID-19 pandemic has served as a wake-up call for governments , health-care professionals and the broader public on the importance of having a robust and resilient domestic pharmaceutical industry .”
“ The COVID-19 pandemic has served as a wake-up call for governments , health-care professionals and the broader public ”
— Jim Keon , President , CGPA
81 healthcareglobal . com